Shared Decision-Making in Hematopoietic Stem Cell Transplantation for Sickle Cell Disease

Biol Blood Marrow Transplant. 2018 May;24(5):883-884. doi: 10.1016/j.bbmt.2018.04.001. Epub 2018 Apr 9.

¹ Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina. Electronic address: sulli025@mc.duke.edu.
² Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
³ Sickle Cell Disease Enterprise, Levine Cancer Institute, Carolinas Healthcare, Atrium Health, Charlotte, North Carolina.
⁴ Adult Sickle Cell Center, Duke University Medical Center, Durham, North Carolina; Division of Hematology, Duke University Medical Center, Durham, North Carolina; Division of Pediatric Hematology/Oncology, Duke University Medical Center, Durham, North Carolina.
⁵ Adult Sickle Cell Center, Duke University Medical Center, Durham, North Carolina; Division of Hematology, Duke University Medical Center, Durham, North Carolina.

No abstract available

Publication types